{Etokimab: A Deep Examination into the 2022981-44-6 Protein Etokimab, designated by the distinct identifier 2022981-44-6, represents a novel antibody currently in clinical evaluation. This biologic agent, targeting https://www.targetmol.com/compound/etokimab